SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency.

Li, Maochen; Lou, Fuxing; Fan, Huahao

Li, Maochen; Lou, Fuxing; Fan, Huahao.

Afiliación

Li M; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Lou F; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Fan H; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. fanhuahao@mail.buct.edu.cn.

Signal Transduct Target Ther ; 6(1): 151, 2021 04 10.

Article en En | MEDLINE | ID: mdl-33839737

Asunto(s)

COVID-19; Vacunas; COVID-19/terapia; Humanos; Inmunización Pasiva; ARN Mensajero; SARS-CoV-2; Sueroterapia para COVID-19

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Signal Transduct Target Ther Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google